TCL Archive Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion June 23, 1995
TCL Archive In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post January 31, 1992
TCL Archive How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment April 13, 2012
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
